Category: Heel Pharmacological Index

  • Lycopodium-Injeel S

    Lycopodium-Injeel S
    D 8, D 12, D 30, D 200, D 1000 0.220 ml each.
    Lycopodium-Injeel forte S
    D 4, D 8, D 12, D 30, D 200,D 1000 0.183 ml each.

    Diseases of the liver, gall bladder and bile duct with loss of appetite or lycorexia and a feeling of satiation after eating very little; meteorism, the patient cannot tolerate anything tight around the abdomen; pale yellowish complexion, uric acid diathesis, tonsillitis (starting on the right side); the patient is distrustful, suspicious, resentful.

  • Tonsilla pharyngica suis-Injeel

    Tonsilla pharyngica suis-Injeel
    (pharyngeal tonsil)

    Lymphatism, hypertrophy of the pharyngeal tonsil, disturbances of mental and physical development.

  • Sabina-Injeel

    Sabina-Injeel
    D 8, D 12, D 30, D 200 0.275 ml each.
    Sabina-Injeel forte
    D 4, D 8, D 12, D 30, D 200 0.220 ml each.

    Menorrhagia, abortus imminens, fluor albus, pains with arthritis and gout of the hand and toe joints (big toes), condylomata acuminata, very irritating.

  • Allium sativum-Injeel

    Allium sativum-Injeel
    D 12, D 30, D 200 0.367 ml each.

    Digestive disorders, with eructation and pyrosis, in patients consuming large amounts of meat.

  • Uterus suis-Injeel

    Uterus suis-Injeel and forte
    (uterus)

    Prolapsus uteri, myomatosis uteri, dysmenorrhoea, precancerous dermatosis of the uterus, erosio uteri, female sterility, other degenerative diseases of the uterus.

  • Arum maculatum-Injeel

    Arum maculatum-Injeel
    D 12, D 30, D 200 0.367 ml each.
    Arum maculatum-Injeel forte
    D 4, D 12, D 30, D 200 0.275 ml each.

    Pharyngitis, laryngitis, hay fever; bulbar syndrome (particularly sialorrhoea); nose, mouth and pharynx inflamed, sore and burning.

  • Selen-Schwefelsäure-Injeel

    Selen-Schwefelsäure-Injeel
    D 10, D 30, D 200 0.367 ml each.

    Conditions of exhaustion, prostration, hyperhidrosis.

  • Bronchus suis-Injeel

    Bronchus suis-Injeel and forte
    (bronchi)

    Emphysema, bronchial asthma, chronic bronchitis, stasis of the pulmonary circulation.

  • Amidopyrin-Injeel

    Amidopyrin-Injeel
    D 12, D 30, D 200 0.367 ml each.

    Agranulocytosis, leukopenia, endocardial, myocardial or pericardial impairment and renal damage, particularly when these are, or have been, associated with a rheumatic attack.

  • Phenothiazin-Injeel

    Phenothiazin-Injeel
    D 12, D 30, D 200 0.367 ml each.

    Phenothiazine derivatives are used as antihistiminics, as psychotherapeutic drugs with ataractic and neuroplegic action, as potentiating preparations (potentiation of pure narcotics/ hypnotics) in anesthesiology, further, to lower the body temperature (artificial hibernation, controlled hypothermia), lytic cocktail, and for the controlled lowering of the blood pressure. Phenothiazine is used in veterinary medicine as an anthelminthic. In human medicine (oxyuriasis), however, it has not been accepted, as it has toxic side effects (internal anemia, renal impairment, particularly nephrosis, as well as hepatic damage). All Contraindications and restrictions on use as well as the side effects, are shown in the Rote Liste (red list, 1979, under P 40. These comprise summarily all phenothiazine, thioxanthene, azaphenothiazine and butyrophenone derivatives: dyskinesias, e.g. torticollis, trismus, Parkinson’s disease, circulatory lability, secretory disturbances of the salivary and sweat glands, gastrointestinal disturbances, urinary disorders, disturbances of the haematopoiesis (agranulocytosis), cholestasia, provocation of epileptic attacks, corneal or lenticular deposits, disturbances in the conduction of stimuli.

    If skin reactions occur as a frequent side effect after the administration of phenothiazine derivatives (see above), it could be considered that lupus erythematosus might be present or that there was a pathological reaction to light.

    Indications

    In accordance with the homoeopathic reversal effect for the above-mentioned symptoms, clinical pictures, etc., especially when these result from therapeutical damage after the application or abuse of psychosomatic drugs of the phenothiazine groups, or when such causation must be assumed. Experimentally also for character changes during/after corresponding therapeutic damage. Phenothiazin-Injeel is unsuited for use as a psychosomatic drug.